On Monday, CorMedix Inc (NASDAQ: CRMD) was 5.61% up from the session before settling in for the closing price of $10.33. A 52-week range for CRMD has been $2.89 – $13.85.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -47.11%. When this article was written, the company’s average yearly earnings per share was at 45.05%. With a float of $59.76 million, this company’s outstanding shares have now reached $60.68 million.
Let’s determine the extent of company efficiency that accounts for 82 employees. In terms of profitability, gross margin is 83.54%, operating margin of -405.54%, and the pretax margin is -378.34%.
CorMedix Inc (CRMD) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward CorMedix Inc stocks. The insider ownership of CorMedix Inc is 1.51%, while institutional ownership is 31.40%. The most recent insider transaction that took place on Nov 14 ’24, was worth 1,565,670. In this transaction EVP of this company sold 140,027 shares at a rate of $11.18, taking the stock ownership to the 45,397 shares. Before that another transaction happened on Nov 14 ’24, when Company’s Officer proposed sale 140,027 for $11.12, making the entire transaction worth $1,556,416.
CorMedix Inc (CRMD) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 45.05% per share during the next fiscal year.
CorMedix Inc (NASDAQ: CRMD) Trading Performance Indicators
You can see what CorMedix Inc (CRMD) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 50.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit 0.03 in the next quarter and is forecasted to reach 0.36 in one year’s time.
Technical Analysis of CorMedix Inc (CRMD)
Looking closely at CorMedix Inc (NASDAQ: CRMD), its last 5-days average volume was 1.07 million, which is a jump from its year-to-date volume of 0.73 million. As of the previous 9 days, the stock’s Stochastic %D was 39.95%. Additionally, its Average True Range was 0.77.
During the past 100 days, CorMedix Inc’s (CRMD) raw stochastic average was set at 71.29%, which indicates a significant increase from 50.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 125.38% in the past 14 days, which was higher than the 84.12% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.63, while its 200-day Moving Average is $5.86. However, in the short run, CorMedix Inc’s stock first resistance to watch stands at $11.11. Second resistance stands at $11.32. The third major resistance level sits at $11.71. If the price goes on to break the first support level at $10.51, it is likely to go to the next support level at $10.12. Should the price break the second support level, the third support level stands at $9.91.
CorMedix Inc (NASDAQ: CRMD) Key Stats
There are 60,677K outstanding shares of the company, which has a market capitalization of 621.67 million. As of now, sales total 0 K while income totals -46,340 K. Its latest quarter income was 11,460 K while its last quarter net income were -2,780 K.
